1. Home
  2. RGEN vs EHC Comparison

RGEN vs EHC Comparison

Compare RGEN & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • EHC
  • Stock Information
  • Founded
  • RGEN 1981
  • EHC 1983
  • Country
  • RGEN United States
  • EHC United States
  • Employees
  • RGEN N/A
  • EHC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • EHC Hospital/Nursing Management
  • Sector
  • RGEN Health Care
  • EHC Health Care
  • Exchange
  • RGEN Nasdaq
  • EHC Nasdaq
  • Market Cap
  • RGEN 7.6B
  • EHC 9.3B
  • IPO Year
  • RGEN N/A
  • EHC 1986
  • Fundamental
  • Price
  • RGEN $156.55
  • EHC $93.10
  • Analyst Decision
  • RGEN Buy
  • EHC Strong Buy
  • Analyst Count
  • RGEN 12
  • EHC 8
  • Target Price
  • RGEN $187.44
  • EHC $106.75
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • EHC 604.7K
  • Earning Date
  • RGEN 02-19-2025
  • EHC 02-06-2025
  • Dividend Yield
  • RGEN N/A
  • EHC 0.74%
  • EPS Growth
  • RGEN N/A
  • EHC 18.07
  • EPS
  • RGEN N/A
  • EHC 4.14
  • Revenue
  • RGEN $633,513,000.00
  • EHC $5,215,000,000.00
  • Revenue This Year
  • RGEN $2.28
  • EHC $12.53
  • Revenue Next Year
  • RGEN $9.88
  • EHC $9.12
  • P/E Ratio
  • RGEN N/A
  • EHC $22.28
  • Revenue Growth
  • RGEN N/A
  • EHC 11.15
  • 52 Week Low
  • RGEN $113.50
  • EHC $67.94
  • 52 Week High
  • RGEN $211.13
  • EHC $104.55
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • EHC 41.88
  • Support Level
  • RGEN $149.15
  • EHC $90.67
  • Resistance Level
  • RGEN $160.64
  • EHC $92.95
  • Average True Range (ATR)
  • RGEN 5.96
  • EHC 1.74
  • MACD
  • RGEN 0.91
  • EHC 0.13
  • Stochastic Oscillator
  • RGEN 79.57
  • EHC 78.12

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Share on Social Networks: